Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Episode 9 • September 01, 2021 • 00:47:27
Episode 9:  Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP
Few & Far Between: How Biotech Gets Built
Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Sep 01 2021 | 00:47:27

/

Show Notes

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

Other Episodes

Episode 3

June 09, 2021 • 00:39:48
Episode Cover

Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be discussing insights into market research solutions for rare...

Listen

Episode 63

October 28, 2025 • 01:01:16
Episode Cover

Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences

What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast...

Listen

Episode 38

May 23, 2024 • 00:35:24
Episode Cover

Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health

"It's amazing how many companies there are and how many opportunities for a kind of a match between a human that needs some help...

Listen